Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Hutterer Georg |

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Moik, F; Terbuch, A; Sprakel, A; Pichler, G; Barth, DA; Pichler, R; Rainer, P; Silbernagel, G; Mannweiler, S; Jost, PJ; Ahyai, SA; Bauernhofer, T; Hutterer, GC; Pichler, M Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.
J Thromb Haemost. 2025; Doi: 10.1016/j.jtha.2025.01.022
PubMed FullText FullText_MUG

 

2024

Full paper/article (Journal)

** Jasarevic, S; Jankovic, D; Hutterer, GC; Riedl, R; Scheipner, L; Schöpfer-Schwab, S; Rosenlechner, D; Seles, M; Primus, G; Ahyai, SA Intermediate- and Long-term Results After Adjustable Transobturator Male System Implantation.
Urology. 2024; Doi: 10.1016/j.urology.2024.11.054
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Scheipner, L; Zurl, H; Altziebler, JV; Pichler, GP; Schöpfer-Schwab, S; Jasarevic, S; Gaisl, M; Pohl, KC; Pemberger, K; Andlar, S; Hutterer, GC; Bele, U; Leitsmann, C; Leitsmann, M; Augustin, H; Zigeuner, R; Ahyai, S; Mischinger, J Charlson-Deyo Comorbidity Index as a novel predictor for recurrence in nonmuscle invasive bladder cancer
EUR UROL. 2024; 85: S2123-S2124. [Oral Communication]
Web of Science

 

2023

Full paper/article (Journal)

** Egger, V; Hutterer, GC; Mischinger, J; Seles, M; Pichler, R; Mannweiler, S; Huber, K; Balihodzic, A; Spiegelberg, J; Bauernhofer, T; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
World J Urol. 2023; 41(5):1359-1364 Doi: 10.1007/s00345-023-04379-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Scheipner, L; Tappero, S; Piccinelli, ML; Barletta, F; Garcia, CC; Incesu, RB; Morra, S; Baudo, A; Tian, Z; Saad, F; Shariat, SF; Terrone, C; De, Cobelli, O; Briganti, A; Chun, FKH; Tilki, D; Longo, N; Carmignani, L; Pichler, M; Hutterer, G; Ahyai, S; Karakiewicz, PI Regional differences in clear cell metastatic renal cell carcinoma patients across the USA.
World J Urol. 2023; 41(11): 2991-3000. Doi: 10.1007/s00345-023-04589-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Scheipner, L; Zurl, H; Altziebler, JV; Pichler, GP; Schöpfer-Schwab, S; Jasarevic, S; Gaisl, M; Pohl, KC; Pemberger, K; Andlar, S; Hutterer, GC; Bele, U; Leitsmann, C; Leitsmann, M; Augustin, H; Zigeuner, R; Ahyai, S; Mischinger, J Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2023; 15(24): Doi: 10.3390/cancers15245770 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Short report/Letter

** Sadoghi, B; Posch, F; Komericki, P; Tripolt-Droschl, K; Kränke, B; Ahyai, SA; Strimitzer-Komericki, T; Hutterer, GC Pre-test probability of sexually transmitted infections in persons presenting to a STI clinic: A prospective study.
J Dtsch Dermatol Ges. 2023; Doi: 10.1111/ddg.15255
Web of Science PubMed FullText FullText_MUG

 

Case Report

** Sadoghi, B; Hutterer, GC; Cerroni, L 'Case of the Month' from the Medical University of Graz, Austria: ulcus durum mimicking squamous cell carcinoma.
BJU Int. 2023; 132(1):31-33 Doi: 10.1111/bju.15892
Web of Science PubMed FullText FullText_MUG

 

2022

Full paper/article (Journal)

** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083 Doi: 10.1002/cam4.4675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13:840207 Doi: 10.3389/fimmu.2022.840207 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065 Doi: 10.1177/17588359221134065 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353 Doi: 10.1016/j.clgc.2022.03.010
Web of Science PubMed FullText FullText_MUG

 

** Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389 Doi: 10.3389/fsurg.2022.1013389 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Hutterer, GC; Pichler, M Renal cell carcinoma-presentation highlights from the ESMO Congress 2021
MEMO-MAG EUR MED ONC. 2022; Doi: 10.1007/s12254-022-00798-6
Web of Science FullText FullText_MUG

 

** Sadoghi, B; Kränke, B; Komericki, P; Hutterer, G Sexually transmitted pathogens causing urethritis: A mini-review and proposal of a clinically based diagnostic and therapeutic algorithm.
Front Med (Lausanne). 2022; 9:931765 Doi: 10.3389/fmed.2022.931765 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16 Doi: 10.1016/j.urolonc.2021.06.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Jasarevic, S; Jankovic, D; Hutterer, GC; Riedl, R; Pichler, GP; Pummer, K; Primus, G Long-Term Results after Suprapubic ARC Procedure for the Treatment of Stress Urinary Incontinence in Women: A Retrospective Data Analysis.
Urol Int. 2021; 105(9-10):777-785 Doi: 10.1159/000516941 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lebentrau, S; Wakileh, GA; Schostak, M; Schmid, HP; Suarez-Ibarrola, R; Merseburger, AS; Hutterer, GC; Necknig, UH; Rink, M; Bögemann, M; Kluth, LA; Pycha, A; Burger, M; Brookman-May, SD; Bründl, J; May, M Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS).
Front Oncol. 2021; 11: 759362 Doi: 10.3389/fonc.2021.759362 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Yuan, P; Sun, X; Liu, X; Hutterer, G; Pummer, K; Hager, B; Ye, Z; Chen, Z Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway.
Phytomedicine. 2021; 86: 153555-153555. Doi: 10.1016/j.phymed.2021.153555
Web of Science PubMed FullText FullText_MUG

 

Case Report

** Sadoghi, B; Komericki, P; Igrec, J; Hutterer, GC; Wolf, P Lymphogranuloma venereum mimicking rectal cancer (T3 N2) and causing a rectovesical fistula.
Int J STD AIDS. 2021; 32(9):878-880 Doi: 10.1177/0956462420948353
Web of Science PubMed FullText FullText_MUG

 

2020

Full paper/article (Journal)

** Distler, FA; Pahernik, S; Gakis, G; Hutterer, G; Lebentrau, S; Rink, M; Nuhn, P; Brookman-May, S; Burger, M; Gratzke, C; Wolff, I; May, M Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey.
World J Urol. 2020; 38(10):2523-2530 Doi: 10.1007/s00345-019-03052-7
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Cancers (Basel). 2020; 12(5): 1200 Doi: 10.3390/cancers12051200 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Barth, DA; Riedl, JM; Asamer, E; Klocker, EV; Kornprat, P; Hutterer, GC; Prinz, F; Lackner, K; Stöger, H; Gerger, A; Pichler, M The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zastrow, S; Krabbe, LM; Wolff, I; Capitanio, U; Klatte, T; Ecke, T; Huck, N; Borgmann, H; Scavuzzo, A; Cindolo, L; Schips, L; Surcel, C; Mirvald, C; Cabo, AV; Musquera, M; Hutterer, G; Prochazkova, K; Stief, C; Wirth, M; May, M; Brookman-May, S External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.
Int J Clin Oncol. 2020; 25(1):145-150 Doi: 10.1007/s10147-019-01530-x
Web of Science PubMed FullText FullText_MUG

 

Case Report

** Lembeck, AL; Puchas, P; Hutterer, G; Barth, DA; Terbuch, A; Bauernhofer, T; Pichler, M MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Noncoding RNA. 2020; 6(1): Doi: 10.3390/ncrna6010002 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Full paper/article (Journal)

** Hutterer, GC; Posch, F; Buser, L; Zigeuner, R; Morshäuser, L; Otto, W; Wild, PJ; Burger, M; May, M; Pichler, M; Brookman-May, SD BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urol Oncol. 2019; 37(7): 510-518. Doi: 10.1016/j.urolonc.2019.04.004
Web of Science PubMed FullText FullText_MUG

 

** Kardoust Parizi, M; Iwata, T; Kimura, S; Janisch, F; Abufaraj, M; Karakiewicz, PI; Enikeev, D; Rapoport, LM; Hutterer, G; Shariat, SF Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2019; 20(6): 1374 Doi: 10.3390/ijms20061374 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mischinger, J; Fröhlich, E; Mannweiler, S; Meindl, C; Absenger-Novak, M; Hutterer, GC; Seles, M; Augustin, H; Chromecki, TF; Jesche-Chromecki, J; Pummer, K; Zigeuner, R Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Cent European J Urol. 2019; 72(1): 23-31. Doi: 10.5173/ceju.2018.1858 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

Review

** Hutterer, GC; Pichler, M Advanced/metastatic urothelial carcinoma of the bladder and upper urinary tract Presentation highlights from the ASCO 2019 Congress
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00532-9
Web of Science FullText FullText_MUG

 

Editorial

** Hutterer, GC Special Issue on Molecular Research Efforts in Urothelial Carcinoma: Summary of Included Topics.
Int J Mol Sci. 2019; 20(15): 3790 Doi: 10.3390/ijms20153790 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Full paper/article (Journal)

** Morshaeuser, L; May, M; Burger, M; Otto, W; Hutterer, GC; Pichler, M; Klatte, T; Wild, P; Buser, L; Brookman-May, S p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Urol Oncol. 2018; 36(3):94.e15-94.e94 Doi: 10.1016/j.urolonc.2017.11.011
Web of Science PubMed FullText FullText_MUG

 

** Smith, MR; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, BA; Graff, JN; Olmos, D; Mainwaring, PN; Lee, JY; Uemura, H; Lopez-Gitlitz, A; Trudel, GC; Espina, BM; Shu, Y; Park, YC; Rackoff, WR; Yu, MK; Small, EJ; SPARTAN Investigators Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
N Engl J Med. 2018; 378(15): 1408-1418. Doi: 10.1056/NEJMoa1715546 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10): Doi: 10.3390/ijms19103130 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Full paper/article (Journal)

** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283 Doi: 10.1371/journal.pone.0176283 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Borgmann, H; Musquera, M; Haferkamp, A; Vilaseca, A; Klatte, T; Shariat, SF; Scavuzzo, A; Jimenez Rios, MA; Wolff, I; Capitanio, U; Dell'Oglio, P; Krabbe, LM; Herrmann, E; Ecke, T; Vergho, D; Huck, N; Wagener, N; Pahernik, S; Zastrow, S; Wirth, M; Surcel, C; Mirvald, C; Prochazkova, K; Hutterer, G; Zigeuner, R; Cindolo, L; Hora, M; Stief, CG; May, M; Brookman-May, SD Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
World J Urol. 2017; 35(12):1891-1897 Doi: 10.1007/s00345-017-2078-5
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Krieger, D; Ehrlich, GC; Pohlmann, K; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma.
Urol Int. 2017; 98(3):320-327 Doi: 10.1159/000452109
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90 Doi: 10.1038/bjc.2016.393 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** May, M; Surcel, C; Capitanio, U; Dell'Oglio, P; Klatte, T; Shariat, S; Ecke, T; Wolff, I; Vergho, D; Wagener, N; Huck, N; Pahernik, S; Zastrow, S; Wirth, M; Borgmann, H; Haferkamp, A; Musquera, M; Krabbe, LM; Herrmann, E; Scavuzzo, A; Mirvald, C; Hutterer, G; Zigeuner, R; Stief, CG; Waidelich, R; Cindolo, L; Kalusova, K; Brookman-May, SD; Collaborative Research On Renal Neoplasms Association (CORONA) and European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
Scand J Urol. 2017; 51(4):269-276 Doi: 10.1080/21681805.2017.1300187
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
J Urol. 2017; 198(6):1247-1252 Doi: 10.1016/j.juro.2017.07.036
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wolff, I; Scavuzzo, A; Capitanio, U; Klatte, T; Shariat, SF; Wagener, N; Zastrow, S; Borgmann, H; Krabbe, LM; Hutterer, G; May, M; Brookman-May, SD; Collaborative Research On Renal Neoplasms Association (CORONA) and the European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study.
Urology. 2017; 109(1):107-114 Doi: 10.1016/j.urology.2017.06.042
Web of Science PubMed FullText FullText_MUG

 

Review

** Schanza, LM; Seles, M; Stotz, M; Fosselteder, J; Hutterer, GC; Pichler, M; Stiegelbauer, V MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(11): Doi: 10.3390/ijms18112495 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

2016

Full paper/article (Journal)

** Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122011 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551 Doi: 10.1038/srep33551 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wolff, I; May, M; Hoschke, B; Zigeuner, R; Cindolo, L; Hutterer, G; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, MD; Salzano, L; Lotrecchiano, G; Shariat, SF; Hohenfellner, M; Waidelich, R; Stief, C; Miller, K; Pahernik, S; Brookman-May, S; Members of the CORONA Project and the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
Eur J Surg Oncol. 2016; 42(5):744-750 Doi: 10.1016/j.ejso.2016.01.009
Web of Science PubMed FullText FullText_MUG

 

Review

** Cerk, S; Schwarzenbacher, D; Adiprasito, JB; Stotz, M; Hutterer, GC; Gerger, A; Ling, H; Calin, GA; Pichler, M Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Int J Mol Sci. 2016; 17(9): Doi: 10.3390/ijms17091485 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 Doi: 10.3390/ijms17040573 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35 Doi: 10.1016/j.juro.2015.01.083
Web of Science PubMed FullText FullText_MUG

 

** Brookman-May, SD; May, M; Wolff, I; Zigeuner, R; Hutterer, GC; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Feciche, B; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, Mdel C; Salzano, L; Lotrecchiano, G; Zastrow, S; Wirth, M; Sountoulides, P; Shariat, S; Waidelich, R; Stief, C; Gunia, S; CORONA Project; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
Eur Urol. 2015; 67(5):943-951 Doi: 10.1016/j.eururo.2014.11.055 [Poster]
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551 Doi: 10.1136/jclinpath-2014-202683
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Krieger, D; Mrsic, E; Pohlmann, K; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Anticancer Res. 2015; 35(6):3463-3469
Web of Science PubMed

 

** Hutterer, GC; Sobolev, N; Ehrlich, GC; Gutschi, T; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R; Pichler, M; Dalpiaz, O Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
J Clin Pathol. 2015; 68(5):351-355 Doi: 10.1136/jclinpath-2014-202658
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years.
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL. Doi: 10.1200/jco.2015.33.7_suppl.513 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents): A European single-center experience over 26 years
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.e15617 [Poster]
Web of Science FullText FullText_MUG

 

2014

Full paper/article (Journal)

** Dalpiaz, O; Ehrlich, GC; Mannweiler, S; Hernández, JM; Gerger, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
BJU Int. 2014; 114(3):334-339 Doi: 10.1111/bju.12441 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mannweiler, S; Martín Hernández, JM; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Br J Cancer. 2014; 110(10):2531-2536 Doi: 10.1038/bjc.2014.180 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Jesche, J; Eberhard, K; Pummer, K; Zigeuner, R; Pichler, M Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Urol Oncol. 2014; 32(7):1041-1048 Doi: 10.1016/j.urolonc.2014.04.001
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Dalpiaz, O; Ehrlich, GC; Stojakovic, T; Martín Hernández, JM; Mannweiler, S; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
J Urol. 2014; 191(4):920-925 Doi: 10.1016/j.juro.2013.10.073
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4): Doi: 10.1200/jco.2014.32.4_suppl.534 [Poster]
Web of Science FullText FullText_MUG

 

2013

Full paper/article (Journal)

** Al-Ali, BM; Shamloul, R; Hutterer, GC; Puchwein, E; Pummer, K; Avian, A; Primus, G Sexual function in women with stress urinary incontinence treated with the SPARC sling system.
Biomed Res Int. 2013; 2013(2):957547-957547 Doi: 10.1155/2013/957547 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Pichler, M; Chromecki, TF; Strini, KA; Klatte, T; Pummer, K; Remzi, M; Mannweiler, S; Zigeuner, R Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.
Histopathology. 2013; 63(3):309-315 Doi: 10.1111/his.12163
Web of Science PubMed FullText FullText_MUG

 

** Mohamad Al-Ali, B; Hutterer, GC; Puchwein, E; Pummer, K; Novara, G; Primus, G Clinical impact of body mass index on the outcome of the SPARC-sling system for the treatment of female stress urinary incontinence.
World J Urol. 2013; 31(4):875-880 Doi: 10.1007/s00345-011-0805-x
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Hoefler, G; Pummer, K; Zigeuner, R Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Histopathology. 2013; 62(2):237-246 Doi: 10.1111/his.12001
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Pummer, K; Zigeuner, R Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
BJU Int. 2013; 111(4 Pt B):E191-E195 Doi: 10.1111/j.1464-410X.2012.11584.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Pummer, K; Mannweiler, S; Zigeuner, R Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.
Histopathology. 2013; 62(2):219-228 Doi: 10.1111/j.1365-2559.2012.04328.x
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Eberhard, K; Gerger, A; Mannweiler, S; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Br J Cancer. 2013; 108(4):901-907 Doi: 10.1038/bjc.2013.28 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
Br J Cancer. 2013; 109(5):1123-1129 Doi: 10.1038/bjc.2013.443 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R A LARGE SCALE VALIDATION STUDY PROPOSES HIGH PRE-OPERATIVE PLASMA FIBRINOGEN LEVELS AS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR REGARDING CANCER-SPECIFIC, METASTASIS-FREE, AS WELL AS OVERALL SURVIVAL IN A EUROPEAN COHORT OF RENAL CELL CARCINOMA PATIENTS
J UROLOGY. 2013; 189(4): E300-E301. Doi: 10.1016/j.juro.2013.02.294 [Poster]
Web of Science FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma.
J Urol. 2012; 187(3):834-839 Doi: 10.1016/j.juro.2011.10.155
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Eberhard, K; Hoefler, G; Pummer, K; Zigeuner, R Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
J Clin Pathol. 2012; 65(8):721-724 Doi: 10.1136/jclinpath-2012-200797
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival.
Int Urol Nephrol. 2012; 44(4):997-1004 Doi: 10.1007/s11255-012-0165-5
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.
Am J Clin Pathol. 2012; 137(2): 283-289. Doi: 10.1309/AJCPLBK9L9KDYQZP [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rainer, PP; Doleschal, B; Kirk, JA; Sivakumaran, V; Saad, Z; Groschner, K; Maechler, H; Hoefler, G; Bauernhofer, T; Samonigg, H; Hutterer, G; Kass, DA; Pieske, B; von, Lewinski, D; Pichler, M Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
BJU Int. 2012; 110(10):1455-62 Doi: 10.1111/j.1464-410X.2012.11134.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Full paper/article (Journal)

** Heidler, S; Ofner-Kopeinig, P; Puchwein, E; Hutterer, GC; Pummer, K; Primus, G Quality of Life after SPARC Sling Procedure: A Long-Term Retrospective Analysis.
Urol Int. 2011; 86(4): 424-426. Doi: 10.1159/000324797
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology.
J Urol. 2011; 186(5):1773-1777 Doi: 10.1016/j.juro.2011.07.034
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2010

Full paper/article (Journal)

** Porter, CR; Suardi, N; Capitanio, U; Hutterer, GC; Kodama, K; Gibbons, RP; Correa, R; Perrotte, P; Montorsi, F; Karakiewicz, PI A nomogram predicting prostate cancer-specific mortality after radical prostatectomy.
Urol Int. 2010; 84(2): 132-140. Doi: 10.1159/000277588 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Eur Urol. 2010; 57(1):102-9 Doi: 10.1016/j.eururo.2008.11.033
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Full paper/article (Journal)

** Capitanio, U; Perrotte, P; Hutterer, GC; Suardi, N; Jeldres, C; Shariat, SF; Duclos, A; Arjane, P; Montorsi, F; Karakiewicz, PI Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
Int J Urol. 2009; 16(1):91-95 Doi: 10.1111/j.1442-2042.2008.02192.x
Web of Science PubMed FullText FullText_MUG

 

** Jeldres, C; Suardi, N; Perrotte, P; Capitanio, U; Walz, J; Hutterer, GC; Saad, F; Valiquette, L; Graefen, M; Widmer, H; Karakiewicz, PI Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.
Can Urol Assoc J. 2009; 3(1):13-21 [OPEN ACCESS]
Web of Science PubMed PUBMED Central

 

** Lotan, Y; Capitanio, U; Shariat, SF; Hutterer, GC; Karakiewicz, PI Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
BJU Int. 2009; 103(10):1368-1374 Doi: 10.1111/j.1464-410X.2009.08360.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Hutterer, GC Editorial comment.
J Urol. 2009; 182(6):2651-2652 Doi: 10.1016/j.juro.2009.08.189
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Stage migration of renal cell carcinoma in a European single centre over 23 years: Impact on survival
European Urology Supplements2009; 8(4):156-156.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60147-0 [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R The Leibovich - mayo clinic scoring algorithm for clear cell renal cell carcinoma supplemented by vascular invasion
European Urology Supplements2009; 8(4):154-154.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60141-X [Poster]
Web of Science FullText FullText_MUG

 

** Jeldres, C; Bhojani, N; Baillargeon-Gagne, S; Isbarn, H; Capitanio, U; Suardi, N; Gallina, A; Hutterer, G; Perrotte, P; Karakiewicz, PI BLADDER CANCER STAGE DISTRIBUTION AT RADICAL CYSTECTOMY IN THE LAST TWO DECADES IN A POPULATION-BASED COHORT
EUR UROL SUPPL. 2009; 8(4): 287-287. [Poster]
Web of Science

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Pummer, K Macroscopic versus microscopic vascular tumour invasion in patients with clear cell renal cell carcinoma: Does it make a difference?
J CLIN ONCOL. 2009; 27(15): 5093 - ASCO Annual Meeting; MAY 29-JUN 3, 2009; Orlando, FL, USA. [Poster]
Web of Science

 

2008

Full paper/article (Journal)

** Bastian, PJ; Hutterer, GC; Shariat, SF; Rogers, CG; Palapattu, GS; Lotan, Y; Vazina, A; Amiel, GE; Gupta, A; Sagalowsky, AI; Lerner, SP; Schoenberg, MP; Karakiewicz, PI; Bladder Cancer Research Consortium Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
BJU Int. 2008; 101(4):450-454 Doi: 10.1111/j.1464-410X.2007.07213.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bhojani, N; Perrotte, P; Hutterer, G; Suardi, N; Jeldres, C; Shariat, SF; Capitanio, U; Arjane, P; Widmer, H; Benard, F; Peloquin, F; Montorsi, F; Karakiewicz, P Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
J Sex Med. 2008; 5(9): 2141-2151. Doi: 10.1111/j.1743-6109.2008.00811.x
Web of Science PubMed FullText FullText_MUG

 

** Bhojani, N; Perrotte, P; Jeldres, C; Suardi, N; Hutterer, G; Shariat, SF; Karakiewicz, PI The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
J Sex Med. 2008; 5(3):668-676 Doi: 10.1111/j.1743-6109.2007.00722.x
Web of Science PubMed FullText FullText_MUG

 

** Gallina, A; Chun, FK; Suardi, N; Eastham, JA; Perrotte, P; Graefen, M; Hutterer, G; Huland, H; Klein, EA; Reuther, A; Montorsi, F; Briganti, A; Shariat, SF; Roehrborn, CG; de la Taille, A; Salomon, L; Karakiewicz, PI Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU Int. 2008; 101(12):1513-1518 Doi: 10.1111/j.1464-410X.2008.07519.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Karakiewicz, PI; Zippe, C; Lüdecke, G; Boman, H; Sanchez-Carbayo, M; Casella, R; Mian, C; Friedrich, MG; Eissa, S; Akaza, H; Serretta, V; Hedelin, H; Rupesh, R; Miyanaga, N; Sagalowsky, AI; Perrotte, P; Lotan, Y; Marberger, MJ; Shariat, SF Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
BJU Int. 2008; 101(5):561-565 Doi: 10.1111/j.1464-410X.2007.07352.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Patard, JJ; Jeldres, C; Perrotte, P; de La Taille, A; Salomon, L; Verhoest, G; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulders, PF; Karakiewicz, PI Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram.
BJU Int. 2008; 101(1): 39-43. Doi: 10.1111/j.1464-410X.2007.07170.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jeldres, C; Suardi, N; Saad, F; Montorsi, F; Shariat, SF; Perrotte, P; Bhojani, N; Walz, J; Hutterer, GC; Graefen, M; Valiquette, L; Karakiewicz, PI High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
Eur Urol. 2008; 54(1):97-105 Doi: 10.1016/j.eururo.2007.10.070
Web of Science PubMed FullText FullText_MUG

 

** Jeldres, C; Suardi, N; Walz, J; Hutterer, GC; Ahyai, S; Lattouf, JB; Haese, A; Graefen, M; Erbersdobler, A; Heinzer, H; Huland, H; Karakiewicz, PI Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
Eur Urol. 2008; 54(6):1306-13 Doi: 10.1016/j.eururo.2007.11.057
Web of Science PubMed FullText FullText_MUG

 

** Jeldres, C; Suardi, N; Walz, J; Saad, F; Hutterer, GC; Bhojani, N; Shariat, SF; Perrotte, P; Graefen, M; Montorsi, F; Karakiewicz, PI Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Eur Urol. 2008; 54(1):107-116 Doi: 10.1016/j.eururo.2007.10.038
Web of Science PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Jeldres, C; Suardi, N; Hutterer, GC; Perrotte, P; Capitanio, U; Ficarra, V; Cindolo, L; de La Taille, A; Tostain, J; Mulders, PF; Salomon, L; Zigeuner, R; Schips, L; Chautard, D; Valeri, A; Lechevallier, E; Descots, JL; Lang, H; Mejean, A; Verhoest, G; Patard, JJ Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.
Can Urol Assoc J. 2008; 2(6):610-617 Doi: 10.5489/cuaj.978 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Leibl, S; Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology.
APMIS. 2008; 116(1): 27-32. Doi: 10.1111/j.1600-0463.2008.00859.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Walz, J; Perrotte, P; Suardi, N; Hutterer, G; Jeldres, C; Bénard, F; Valiquette, L; Graefen, M; Montorsi, F; Karakiewicz, PI Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
J Sex Med. 2008; 5(2):428-435 Doi: 10.1111/j.1743-6109.2007.00662.x
Web of Science PubMed FullText FullText_MUG

 

** Walz, J; Suardi, N; Hutterer, GC; Perrotte, P; Gallina, A; Bénard, F; Valiquette, L; McCormack, M; Graefen, M; Montorsi, F; Karakiewicz, PI Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
J Endourol. 2008; 22(2):369-376 Doi: 10.1089/end.2007.0135
Web of Science PubMed FullText FullText_MUG

 

** Walz, J; Suardi, N; Shariat, SF; Jeldres, C; Perrotte, P; Graefen, M; Widmer, H; Arjane, P; Valiquette, L; Hutterer, G; Saad, F; Karakiewicz, PI Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
BJU Int. 2008; 102(1):33-38 Doi: 10.1111/j.1464-410X.2008.07614.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Bhojani, N; Jeldres, C; Patard, JJ; Perrotte, P; Suardi, N; Hutterer, G; Patenaude, F; Oudard, S; Karakiewicz, PI Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.
Eur Urol. 2008; 53(5):917-930 Doi: 10.1016/j.eururo.2007.11.037
Web of Science PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Hutterer, GC Predictive models and prostate cancer.
Nat Clin Pract Urol. 2008; 5(2):82-92 Doi: 10.1038/ncpuro0972
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Sarcomatoid transformation and collecting system invasion: Independent prognostic indicators in patients with renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):133-133.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60248-1 [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Is the late occurrence of metastases associated with prolonged survival in renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):260-260.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60754-X [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Macrovascular vs. Microvascular tumour invasion in patients with renal cell carcinoma: Does it make a difference ?
EUR UROL SUPPL. EUROPEAN UROLOGY SUPPLEMENTS 2008; 7(3):134-134.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60253-5 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Tumour necrosis: An independent prognostic indicator for clear cell, as well as papillary renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):135-135.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60258-4 [Poster]
Web of Science FullText FullText_MUG

 

** Karakiewicz, PI; Hutterer, GC; Suardi, N; Chromecki, T; Jeldres, C; Kampel-Kettner, K; Innamovic, A; Zigeuner, R; Bensaleh, K; Avakian, R; Shariat, SF; Montorsi, F; Perrotte, P; Patard, JJ Nomogram predicting renal cancer-specific survival in surgically treated patients with metastatic renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):282-282.-23rd Annual EAU (European Association of Urology) Congress; 26-29 March 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60840-4 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Kampel-Kettner, K; Imamovic, A; Langner, C; Rehak, P; Pummer, K The mayo clinic stage, size, grade and necrosis (SSIGN) score for clear cell renal cell carcinoma: External validation by a single European centre applying routine pathology
EUR UROL SUPPL. 2008; 7(3):280-280.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60832-5 [Poster]
Web of Science FullText FullText_MUG

 

2007

Full paper/article (Journal)

** Briganti, A; Chun, FK; Hutterer, GC; Gallina, A; Shariat, SF; Salonia, A; Scattoni, V; Valiquette, L; Montorsi, F; Rigatti, P; Graefen, M; Huland, H; Karakiewicz, PI Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
Eur Urol. 2007; 52(3):733-743 Doi: 10.1016/j.eururo.2007.02.054
Web of Science PubMed FullText FullText_MUG

 

** Briganti, A; Shariat, SF; Chun, FK; Hutterer, GC; Roehrborn, CG; Gallina, A; Rigatti, P; Valiquette, L; Montorsi, F; Karakiewicz, PI Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.
BJU Int. 2007; 100(3):528-532 Doi: 10.1111/j.1464-410X.2007.07005.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Chun, FK; Hutterer, GC; Perrotte, P; Gallina, A; Valiquette, L; Benard, F; McCormack, M; Briganti, A; Ionescu, C; Jeldres, C; Guay, JP; Saad, F; Karakiewicz, PI Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
BJU Int. 2007; 100(1):37-41 Doi: 10.1111/j.1464-410X.2007.06923.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Chun, FKH; Briganti, A; Gallina, A; Hutterer, GC; Shariat, SF; Antebie, E; Walz, J; Roehrborn, CG; Salonia, A; Rigatti, P; Saad, F; Huland, H; Montotsi, F; Graefen, M; Karakiewicz, PI Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
Eur Urol. 2007; 52(4):1067-1074 Doi: 10.1016/j.eururo.2007.03.018
Web of Science PubMed FullText FullText_MUG

 

** Gallina, A; Briganti, A; Chun, FK; Walz, J; Hutterer, GC; Erbersdobler, A; Eichelberg, C; Schlomm, T; Ahyai, SA; Perrotte, P; Saad, F; Montorsi, F; Huland, H; Graefen, M; Karakiewicz, PI Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
BJU Int. 2007; 100(6):1249-53 Doi: 10.1111/j.1464-410X.2007.07147.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gallina, A; Karakiewicz, PI; Hutterer, GC; Chun, FK; Briganti, A; Walz, J; Antebi, E; Shariat, SF; Suardi, N; Graefen, M; Erbersdobler, A; Salonia, A; Rigatti, P; Huland, H; Montorsi, F Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
Int J Cancer. 2007; 121(4):791-795 Doi: 10.1002/ijc.22730 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, G; Perrotte, P; Gallina, A; Walz, J; Jeldres, C; Traumann, M; Suardi, N; Saad, F; Bénard, F; Valiquette, L; McCormack, M; Graefen, M; Montorsi, F; Karakiewicz, PI Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
Eur J Cancer. 2007; 43(7):1180-1187 Doi: 10.1016/j.ejca.2007.01.005
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Patard, JJ; Colombel, M; Belldegrun, AS; Pfister, C; Guille, F; Artibani, W; Montorsi, F; Pantuck, AJ; Karakiewicz, PI Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
Cancer. 2007; 110(11):2428-2433 Doi: 10.1002/cncr.23054 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Patard, JJ; Perrotte, P; Ionescu, C; de La Taille, A; Salomon, L; Verhoest, G; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Chautard, D; Descotes, JL; Rambeaud, JJ; Mejean, A; Karakiewicz, PI Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram.
Int J Cancer. 2007; 121(11): 2556-2561. Doi: 10.1002/ijc.23010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Karakiewicz, PI; Hutterer, GC Predicting outcomes in patients with urologic cancers.
Curr Opin Support Palliat Care. 2007; 1(3): 153-168. Doi: 10.1097/SPC.0b013e3282f125ec
PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Hutterer, GC; Trinh, QD; Jeldres, C; Perrotte, P; Gallina, A; Tostain, J; Patard, JJ C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
Cancer. 2007; 110(6):1241-1247 Doi: 10.1002/cncr.22896 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Hutterer, GC; Trinh, QD; Pantuck, AJ; Klatte, T; Lam, JS; Guille, F; de La Taille, A; Novara, G; Tostain, J; Cindolo, L; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Chautard, D; Lechevallier, E; Valeri, A; Descotes, JL; Lang, H; Soulie, M; Ferriere, JM; Pfister, C; Mejean, A; Belldegrun, AS; Patard, JJ Unclassified renal cell carcinoma: an analysis of 85 cases.
BJU Int. 2007; 100(4): 802-808. Doi: 10.1111/j.1464-410X.2007.07148.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Karakiewicz, PI; Trinh, QD; Bhojani, N; Bensalah, K; Salomon, L; de la Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A; Patard, JJ Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
EUR UROL. 2007; 51(6): 1616-1624. Doi: 10.1016/j.eururo.2006.12.015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Walz, J; Gallina, A; Hutterer, G; Perrotte, P; Shariat, SF; Graefen, M; McCormack, M; Bénard, F; Valiquette, L; Saad, F; Karakiewicz, PI Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2007; 69(1): 88-94. Doi: 10.1016/j.ijrobp.2007.02.022
Web of Science PubMed FullText FullText_MUG

 

** Walz, J; Gallina, A; Perrotte, P; Jeldres, C; Trinh, QD; Hutterer, GC; Traumann, M; Ramirez, A; Shariat, SF; McCormack, M; Perreault, JP; Bénard, F; Valiquette, L; Saad, F; Karakiewicz, PI Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
BJU Int. 2007; 100(6): 1254-1258. Doi: 10.1111/j.1464-410X.2007.07130.x
Web of Science PubMed FullText FullText_MUG

 

** Walz, J; Perrotte, P; Hutterer, G; Suardi, N; Jeldres, C; Bénard, F; Valiquette, L; Karakiewicz, PI Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
BJU Int. 2007; 100(6): 1307-1311. Doi: 10.1111/j.1464-410X.2007.07250.x
Web of Science PubMed FullText FullText_MUG

 

** Winkler, A; Zigeuner, R; Rehak, P; Hutterer, G; Chromecki, T; Langner, C CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
Virchows Arch. 2007; 450(1):59-64 Doi: 10.1007/s00428-006-0316-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zorn, KC; Gallina, A; Hutterer, GC; Walz, J; Shalhav, AL; Zagaja, GP; Valiquette, L; Gofrit, ON; Orvieto, MA; Taxy, JB; Karakiewicz, PI External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.
J ENDOUROL. 2007; 21(11): 1345-1351. Doi: 10.1089/end.2007.0044
Web of Science PubMed FullText FullText_MUG

 

Review

** Karakiewicz, PI; Hutterer, GC Predicting cancer-control outcomes in patients with renal cell carcinoma.
Curr Opin Urol. 2007; 17(5): 295-302. Doi: 10.1097/MOU.0b013e3282a4a6b7
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Karakiewicz, PI; Trinh, QD; Bhojani, N; Bensalah, K; Salomon, L; De La Talle, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A; Patard, JJ Presence of systemic symptoms is the foremost predictor of mortality in patients with exclusive nodal metastases
EUR UROL SUPPL. 2007; 6(2):64-64.-22. Kongreß der “European Association of Urology” (EAU); 21.3.-24.3.2007; Berlin, Germany. [Poster]
Web of Science

 

** Karakiewicz, PI; Trinh, QD; Hutterer, GC; Bhojani, N; Bensalah, K; Patard, JJ; Salomon, L; De La Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A A nomogram predicting renal cell carcinoma-specific survival in patients with nodal metastases is more accurate than any individual variable
EUR UROL SUPPL. 2007; 6(2):64-64.-22. Kongreß der “European Association of Urology” (EAU); 21.-24.3.2007; Berlin, Germany. [Poster]
Web of Science

 

Comment

** Hutterer, GC; Karakiewicz, PI Can the AJCC staging system risk-stratify patients with localized prostate cancer?
Nat Clin Pract Urol. 2007; 4(9):482-483 Doi: 10.1038/ncpuro0885
Web of Science PubMed FullText FullText_MUG

 

2006

Full paper/article (Journal)

** Bauer, M; Hutterer, G; Eder, M; Majer, S; Leshane, E; Johnson, KL; Peter, I; Bianchi, DW; Pertl, B A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Prenat Diagn. 2006; 26(9):831-836 Doi: 10.1002/pd.1513
Web of Science PubMed FullText FullText_MUG

 

** Langner, C; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Zigeuner, R Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract.
J UROL. 2006; 176(3): 910-913. Doi: 10.1016/j.juro.2006.04.019
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Hutterer, G; Chromecki, T; Rehak, P; Zigeuner, R Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.
VIRCHOWS ARCHIV. 2006; 448(5): 604-611. Doi: 10.1007/s00428-006-0150-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Hutterer, G; Chromecki, T; Winkelmayer, I; Rehak, P; Zigeuner, R pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract.
MODERN PATHOL. 2006; 19(2): 272-279. Doi: 10.1038/modpathol.3800529 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Rupar, G; Leibl, S; Hutterer, G; Chromecki, T; Hoefler, G; Rehak, P; Zigeuner, R Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
Virchows Arch. 2006; 448(3):325-330 Doi: 10.1007/s00428-005-0129-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, RE; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
BJU Int. 2006; 98(6): 1181-1186. Doi: 10.1111/j.1464-410X.2006.06519.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Impact of tumor stage, tumor grade, and vascular invasion on metastasis-free survival of patients with urothelial carcinoma of the upper urinary tract.
J UROL. ; 175: 352-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)33319-6 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract.
J UROL. 175: 351-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)33318-4 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression
J UROL. 2006; 175: 132-132.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32661-2 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract correlates with disease progression and metaplastic morphology
J UROL. ; 175: 239-239.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32971-9 [Poster]
Web of Science FullText FullText_MUG

 

2005

Full paper/article (Journal)

** Schips, L; Lipsky, K; Hebel, P; Hutterer, G; Gidaro, S; Petritsch, PH; Zigeuner, RE Laparoscopic fenestration of lymphoceles after kidney transplantation with diaphanoscopic guidance.
UROLOGY. 2005; 66(1): 185-187. Doi: 10.1016/j.urology.2005.02.020
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint